Pharmacovigilance – News and Features

Use of a mouse genetic analysis method may lead to a better understanding of how drugs are metabolized.

The nanotubes, which are hollow inorganic nanostructures derived from clay, allow the linear, controlled release of drugs.

Scientists uses the Mol-Switch with time-resolved fluorescence for DNA sequencing.

The method is expected to be synergistic with existing pharmacogenomic approaches.

The patented Mitox™ technology covers the measurement of mitochondrial DNA and RNA as a biomarker in the assessment of efficacy and unwanted adverse events of treatment.

CYP2D6 affects the metabolism of a large number of compounds, including several commonly prescribed cardiovascular, anti-depressant and analgesic drugs.

A brand new laboratory, which includes a GMP facility and pharmaceutical and chemical laboratories, has been set up.

Protein MBD2 mediates silencing of the fetal gamma-globin gene through DNA methylation.

The Expanded Access Program extends the clinical applications of the world's first targeted genetic medicine to many more cancer patients.

Third Wave will accelerate and expand the development of high-value clinical products for the Japanese molecular diagnostic market.